Jan Rydfors
Reproductive Endocrinology · Redwood City, CANPI 1508810763
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,437 of the $3,589 with a category attached, or 67.9%. 32 manufacturers reported payments, led by Ferring Pharmaceuticals Inc. at 35.9% of the total. Reporting peaked in 2019 at $1,735 and has fallen 89.2% since, to $188 in 2025.
Across 123 payments — averaging $29.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$1K
- AbbVie$733
- Pfizer$181
- Hologic Sales And Service, LLC$162
- Roche Diagnostics Corporation$138
- Myovant Sciences Inc.$106
- plus $980 from 26 others
What the payments were for
- Travel & lodging$1,09831%
- Food & beverage$2,43768%
- Education$542%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 13 | $1,290 |
| AbbVie | 34 | $733 |
| Pfizer | 9 | $181 |
| Hologic Sales And Service, LLC | 8 | $162 |
| Roche Diagnostics Corporation | 7 | $138 |
| Myovant Sciences Inc. | 5 | $106 |
| Sumitomo Pharma America, Inc. | 3 | $71 |
| Avion Pharmaceuticals | 5 | $68 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $66 |
| Evofem Biosciences, Inc. | 3 | $59 |
| Stryker | 1 | $53 |
| Dexcom, Inc. | 2 | $49 |
| AMAG Pharmaceuticals, Inc. | 3 | $48 |
| Kaleo, Inc. | 2 | $45 |
| Exeltis, USA Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $45 |
| Novo Nordisk | 2 | $43 |
| Johnson & Johnson | 1 | $43 |
| Minerva Surgical, Inc | 2 | $40 |
| Bayer | 2 | $34 |
| Merck | 2 | $34 |
| Cranial Technologies, Inc | 2 | $33 |
| Channel Medsystems, Inc. | 1 | $33 |
| Astellas Pharma US Inc | 1 | $33 |
| Coopersurgical, Inc. | 1 | $21 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| Aspira Women's Health Inc | 1 | $17 |
| Agiliti Surgical, Inc. | 1 | $16 |
| Axonics, Inc. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Sage Therapeutics, LLC | 1 | $15 |
| Olympus America Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVOCELL$1,114
How this compares
$3,589 in reported general payments places this provider in the 85th percentile of 230 reproductive endocrinology providers in California.
See all reproductive endocrinology providers in California →
Other reproductive endocrinology in Redwood City
- Sharon WinerBeverly Hills$449K
- Sanjay Agarwalla Jolla$262K
- Valerie FloresSan Diego$184K
- Monica PasternakSan Francisco$77K
- Linda GiudiceSan Francisco$67K
- Valerie BakerSan Jose$66K
- Lisa BechtNewport Beach$48K
- Alexander QuaasSolana Beach$40K
- Shahin GhadirBeverly Hills$31K
- Donna ShoupeLos Angeles$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.